For low-grade glioma cases with an actionable mutation, protein profiles of EGFR_pY1068, HER2_pY1248, HER2, IGFBP2, EGFR_pY1173, and STAT5-alpha are decreased. This evidence concerns the gene IGFBP2 and central nervous system cancer.